Physician-initiated courtesy MODS testing for TB and MDR-TB diagnosis and patient management

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 5, 2008, Pages 555-560

  Nic Fhogartaigh, Caoimhe J ^a,b   Vargas Prada, S ^a   Huancare V ^a   Lopez, S ^a   Rodriguez J ^a   Moore, D A J ^a,b,c  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnosis; MODS; Multidrug resistance (MDR); Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CHILD; DIAGNOSTIC TEST; DRUG SENSITIVITY; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PATIENT CARE MANAGEMENT; PATIENT SELECTION; PERU; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 43949129118     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Suárez P G, Watt C J, Alarcón E, et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 2001; 184: 473-478.
2. Kawai V, Soto G, Gilman R H, et al. Tuberculosis mortality, drug resistance and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg 2006; 75: 1027-1033.
3. Golub J E, Bur S, Cronin W A, et al. Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state. Int J Tuberc Lung Dis 2005; 9: 992-998.
4. Paynter S, Hayward A, Wilkinson P, Lozewicz S, Coker R. Patient and health service delays in initiating treatment for patients with pulmonary tuberculosis: a retrospective cohort study. Int J Tuberc Lung Dis 2004; 8: 180-185.
5. Yimer S, Bjune G, Alene G. Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia. BMC Infect Dis 2005; 12: 112.
6. Lambert M L, Delgado R, Michaux G, Volz A, Speybroek N, Van Der Stuyft P. Delays to treatment and out-of-pocket medical expenditure for tuberculosis patients in an urban area of South America. Ann Trop Med Parasitol 2005; 99: 781-787.
7. Wandwalo E R, Morkve O. Delay in tuberculosis case-finding and treatment in Mwanza, Tanzania. Int J Tuberc Lung Dis 2000; 4: 132-138.
8. Lonroth K, Thuong L M, Linh P D, Diwan V K. Delay and discontinuity - a survey of TB patients search of a diagnosis in a diversified health care system. Int J Tuberc Lung Dis 1999; 3: 992-1000.
9. Yagui M, Perales M T, Ascencios L, et al. Timely diagnosis of MDR-TB under programme conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis 2006; 10: 838-843.
10. Caviedes L, Lee T S, Gilman R H, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208.
11. Moore D A J, Mendoza D, Gilman R H, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42: 4432-4437.
12. Moore D A J, Evans C A W, Gilman R H, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. New Engl J Med 2006; 355: 1539-1550.
13. World Health Organization. Anti-tuberculosis drug resistance in the world: 3rd global report. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance, 1999-2002. WHO/CDS/TB/2000.278. Geneva, Switzerland: WHO, 2004.
14. Farmer P, Kim J Y. Community based approaches to the control of multidrug resistant tuberculosis: introducing 'DOTS-plus'. BMJ 1998; 317: 671-674.
15. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119-128.
16. Shin S, Furin J, Bayona J, Mate K, Kim J Y, Farmer P. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med 2004; 59: 1529-1539.
17. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361. Geneva, Switzerland: WHO, 2006.